Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

The investigators noted that difficult cannulations during ERCP have a frequency of 42%. Cannulation failure is associated ...

Citing a “new evidenced based philosophy,” the FDA’s Center for Biologics Evaluation and Research (CBER) is preparing to take ...

GLP-1a treatment in patients with polycythemia vera was linked to significant reductions in mortality, disease progression, ...

A randomized controlled trial aimed to determine whether providing information on patient risk for advanced colorectal neoplasia (ACN) to patients and providers affects colorectal cancer (CRC) ...

Nearly every modern guideline (from the World Health Organization to the FDA) requires systematic reviews as the foundation ...

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer Electronic patient self-Reporting of Adverse ...

In this randomized, controlled trial involving patients with very high use of health care services, readmission rates were not lower among patients randomly assigned to the Coalition’s program ...

Because of ethical considerations, scientists haven’t been able to conduct randomized controlled trials to conclusively prove the effectiveness of mask-wearing on interrupting coronavirus ...

In randomized trials of such agents when there is already established efficacy, patients randomly assigned to the control arm who progress might then naturally qualify for the investigational drug in ...

This 56-week, randomized, placebo-controlled trial aimed to evaluate the efficacy and safety of 3.0 mg of liraglutide, injected subcutaneously once daily, as an adjunct to a reduced-calorie diet ...